Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
Claire Bridel, Wessel N van Wieringen, Henrik Zetterberg, Betty M Tijms, Charlotte E Teunissen et al.
JAMA neurology, Journal article 2019
Journal article

Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence.
Serena Spudich, Julia Peterson, Dietmar Fuchs, Richard W Price, Magnus Gisslén
AIDS (London, England), Journal article 2019
Journal article

Defining cerebrospinal fluid HIV RNA escape: editorial review AIDS.
Alan Winston, Andrea Antinori, Paola Cinque, Howard S Fox, Magnus Gisslén et al.
AIDS (London, England), Editorial letter 2019
Editorial letter

HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
Sarah B Joseph, Laura P Kincer, Natalie M Bowman, Chris Evans, Michael J Vinikoor et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Journal article 2019
Journal article

Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
Thomas A Premeaux, Michelle L D'Antoni, Mohamed Abdel-Mohsen, Satish K Pillai, Kalpana J Kallianpur et al.
Journal of neurovirology, Journal article 2019
Journal article

Showing 71 - 80 of 172

2013

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection.
Michael J Peluso, Dieter J Meyerhoff, Richard W Price, Julia Peterson, Evelyn Lee et al.
The Journal of infectious diseases, Journal article 2013
Journal article

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy.
Aylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, Richard W Price, Kathryn Crozier et al.
Journal of neuroinflammation, Journal article 2013
Journal article

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
Jan Jessen Krut, Henrik Zetterberg, Kaj Blennow, Paola Cinque, Lars Hagberg et al.
Journal of neurology, Journal article 2013
Journal article

2012

Primary HIV-1 infection is characterized by elevation of cerebrospinal fluid biomarkers indicating early neuronal damage
M. Peluso, R. Price, J. Peterson, E. Lee, D. Fuchs et al.
Journal of Neurovirology, Journal article 2012
Journal article

Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load
U. Karlsson, L. Antonsson, B. Ljungberg, P. Medstrand, J. Esbjornsson et al.
Aids, Journal article 2012
Journal article

Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003-2010.
Annika Karlsson, Per Björkman, Göran Bratt, Håkan Ekvall, Magnus Gisslén et al.
PloS one, Journal article 2012
Journal article

Antiretroviral drug treatment of CNS HIV-1 infection.
Aylin Yilmaz, Richard W Price, Magnus Gisslén
The Journal of antimicrobial chemotherapy, Journal article 2012
Journal article

Showing 71 - 80 of 172

Page Manager: Chatrine Butler|Last update: 8/28/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?